Novartis wins FDA breakthrough therapy for AML treatment savita21 Feb 2016 8:39 AM ISTZurich: Novartis received breakthrough therapy designation from the U.S. Food and Drug Administration for an investigational treatment for...
Suven Life Sciences gets patent for neuro-degenerative drug savita20 Feb 2016 12:16 PM ISTNew Delhi: Drug firm Suven Life Sciences has been granted a patent each by Australia and Canada for a drug used in the treatment of neuro-degenerative...
Zydus Cadila gets US FDA nod for Doxycycline capsules savita20 Feb 2016 12:11 PM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market its generic Doxycycline capsules used for the treatment...
Cipla acquires two US drug firms for $550 mn savita19 Feb 2016 8:16 AM ISTDrug major Cipla has acquired two US-based firms -- InvaGen Pharmaceuticals and Exelan Pharmaceuticals -- for $550 million, the company said in a...
Glenmark gets tentative nod from USFDA for azelaic acid gel savita18 Feb 2016 10:45 AM ISTNEW DELHI: Glenmark Pharmaceuticals today announced receipt of tentative approval from USFDA for its generic version of azelaic acid topical gel used...
Awaiting USFDA response on remediation efforts of 3 units: Dr Reddys Laboratories savita18 Feb 2016 9:44 AM ISTNEW DELHI: Dr Reddy's Laboratories (DRL) is awaiting a response from USFDA for future course of action over its three plants, for which the health...
AstraZeneca wins FDA breakthrough status for durvalumab savita18 Feb 2016 9:16 AM ISTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
Govt may come out with new bulk drug policy in a month: Minister Hansraj Ahir savita17 Feb 2016 11:32 AM ISTMumbai: The government is expected to announce the new bulk drug policy in a month's time, which is expected to bring down imports, Union Minister...
Govt approves investment by FIL Capital in Cipla Health savita17 Feb 2016 8:16 AM ISTNew Delhi : Drug major Cipla said the government has approved an investment by Mauritius-based FIL Capital Investments in its subsidiary, Cipla Health...
1 In 7 Indian drugs revealed as sub-standard savita16 Feb 2016 12:11 PM ISTNew Delhi: Substandard medicines could be three times more prevalent than the government says, two new studies show.These data have serious...
Europe approves Biocon's Rosuvastatin Calcium tablets savita16 Feb 2016 11:20 AM ISTBengaluru: Biotech major Biocon has received its first generic formulation approval in Europe, paving way for the company to launch Rosuvastatin...
PPP in primary healthcare brings encouraging results in Rajasthan savita15 Feb 2016 10:49 AM ISTNew Delhi/Jaipur: A glucometer that scans retina, a mammogram that allows diagnoses of breast cancer without touching, a medicine vending machine and...
